¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hoxose monophosphate shunt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® shunt ÇÑ±Û Áö¸§±æ, Áö¸§¼ú, ´Ü¶ô
¼³¸í   
  1. ÇÑÂÊÀ¸·Î µ¹¾Æ°¡´Ù, ÀüȯÇÏ´Ù, ¿ìȸÇÏ´Ù. 2. Ç÷°ü°£ÀÇ Åë·Î ¶Ç´Â ¿¬°á.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic adenosine monophosphate
    °í¸®ÇüAMP
  • guanosine monophosphate
    ÀÏÀλ걸¾Æ³ë½Å
  • hexose monophosphate
    À°Åº´çÀÏÀλê
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®
  • bypass shunt
    ¿ìȸ¼ÇÆ®
  • cardiovascular shunt
    ½ÉÀåÇ÷°ü¼ÇÆ®
  • intracardiac shunt
    ½ÉÀå³»¼ÇÆ®
  • left-to-right shunt
    Á¿ì¼ÇÆ®
  • lumboperitoneal shunt
    ¿äÃߺ¹°­¼ÇÆ®
  • mesocaval shunt
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®
  • mesocaval shunt operation
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®¼ö¼ú
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®
  • portocaval shunt operation
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®¼ö¼ú
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼ÇÆ®
  • peritoneovenous shunt
    º¹°­Á¤¸Æ¼ÇÆ®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • shunt circuit
    Áö¸§±æ
  • portocaval shunt operation
    ¹®¸Æ´ëÁ¤¸ÆÁö¸§¼ú, ¹®¸Æ´ëÁ¤¸Æ¿¬°á¼ú
  • shunt operation
    Áö¸§¼ú, ´Ü¶ô¼ú, ¼ÇÆ®¼ö¼ú
  • shunt
    Áö¸§±æ, Áö¸§¼ú, ¼ÇÆ®, »çÀÕ±æ
  • lumboperitoneal shunt
    ¿äÃߺ¹°­Áö¸§¼ú
  • peritoneovenous shunt
    º¹°­Á¤¸ÆÁö¸§¼ú, ¹è¸·Á¤¸ÆÁö¸§¼ú
  • right to left shunt
    ¿À¸¥¿ÞÁö¸§±æ
  • transjugular intrahepatic portosystemic shunt
    ¸ñÁ¤¸Æ°æÀ¯°£¼Ó¹®¸ÆÀü½Å¼øÈ¯Áö¸§¼ú, ¸ñÁ¤¸Æ°æÀ¯°£¼Ó¹®¸ÆÀü½Å¼øÈ¯¿¬°á¼ú
  • ventriculoperitoneal shunt
    ³ú½Çº¹°­Áö¸§¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic adenosine monophosphate
    °í¸®¿¡ÀÌ¿¥ÇÇ
  • hexose monophosphate
    À°Åº´çÀÏÀλê
  • arteriovenous shunt
    µ¿Á¤¸ÆÁö¸§±æ, µ¿Á¤¸ÆÁö¸§¼ú
  • bypass shunt
    ¿ìȸ·ÎÁö¸§±æ, ¿ìȸ·ÎÁö¸§¼ú
  • cardiaovascular shunt
    ½ÉÀåÇ÷°üÁö¸§±æ
  • shunt circuit
    Áö¸§±æ
  • shunt effect
    Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
  • intracardiac shunt
    ½ÉÀå³»Áö¸§±æ
  • mesocaval shunt operation
    âÀÚ°£¸·´ëÁ¤¸Æ¿¬°á¼ú, Àå°£¸·Á¤¸Æ´ëÁ¤¸Æ¿¬°á¼ú
  • shunt malfunction
    Áö¸§±æ±â´ÉÀå¾Ö
  • shunt operation
    Áö¸§¼ú, ´Ü¶ô¼ö¼ú
  • paracellular shunt
    ¼¼Æ÷ÁÖÀ§Áö¸§±æ
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸ÆÁö¸§(¼ú), ¹®¸Æ´ëÁ¤¸Æ¿¬°á(¼ú)
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼øÈ¯Áö¸§¼ú, ¹®¸ÆÀü½Å¼øÈ¯¿¬°á¼ú
  • renal shunt
    ÄáÆÏÇ÷·ùÁö¸§±æ, ½ÅÀåÇ÷·ùÁö¸§±æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hexose monophosphate shunt
    À°Åº´çÀÏÀλ꿰ȸ·Î
  • hexose monophosphate shunt
    ÀÏÀλêÇí¼Ò½º¼ÇÆ®<--´Ü¶ô>
  • Guanosine monophosphate (GMP)
    ÀÏÀλ걸¾Æ³ë½Å
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine monophosphate
    ÀÏÀÎ»ê¾Æµ¥³ë½Å
  • adenosine monophosphate =AMP
    ÀÏÀÎ»ê¾Æµ¥³ë½Å.
  • hexose monophosphate
    ÀÏÀλêÇí¼Ò½º.
  • Torkildsons shunt
    Åäųµå½¼´Ü¶ô.
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­Ó­Õ©)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­´Ü¶ô).
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸Æ¹®ÇÕ(¼ú)(¹®¸Æ´ëÁ¤¸Æ¹®ÇÕ¼ú).
  • porto-systemic shunt
    ¹®¸ÆÃ¼´Ü¶ô(Ó­Õ©)<--¼ÇÆ®>
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼øÈ¯¹®ÇÕ¼ú(Ú¦Øæîïãóâàü»Ùüùêâú), ¹®¸ÆÀü½Å¼øÈ¯¼ÇÆ®((Ú¦Øæîïãóâàü»¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hexose monophosphate shunt
    ÀÏÀλêÇí¼Ò½º¼ÇÆ®<--´Ü¶ô>
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine monophosphate
    ÀÏÀÎ»ê¾Æµ¥³ë½Å
  • adenosine monophosphate =AMP
    ÀÏÀÎ»ê¾Æµ¥³ë½Å.
  • cyclic adenosine monophosphate
    °í¸® AMP
  • hexose monophosphate
    ÀÏÀλêÇí¼Ò½º.
  • thymolphthalein monophosphate
    Ƽ¸ôÅ»·¹ÀÎÀÏÀλ꿰
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­Ó­Õ©)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­´Ü¶ô).
  • bypass shunt
    ¿ìȸ·Î ´Ü¶ô(éæüÞÖØÓ­Õ©).
  • bypass shunt
    ȸ·Î°£µµ, ȸ·Î´Ü¶ô(ȸ·Î´Ü¶ô), ¿ìȸ·Î´Ü¶ô.
  • bypass shunt
    ¼øÈ­ [½Å¿Ü,ÈäºÎ]ȸ ·Î°£µµ, ȸ·Î´Ü¶ô(üßÖØÓ­Õ©), ¿ìȸ·Î´Ü¶ô.
  • cardiac shunt
    ½É´Ü¶ô(ãýÓ­Õ©)
  • intracardiac shunt
    ½ÉÀå³»´Ü¶ô(¡­Ó­Õ©).
  • juxtamedullary shunt
    (¼öÁú)±ÙÁ¢ºÎ´Ü¶ô(âÐòõÐÎïÈݻӭթ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hoxose monophosphate shunt
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º ºÐ·Î(ÝÂÖØ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hoxose phosphoketolase pathway
    Çí¼Ò½º Æ÷½ºÆ÷ŰÅç·¹À̽º °æ·Î(ÌèÖØ)
  • GABA shunt
    GABA ºÐ·Î(ÝÂÖØ)
  • HMP shunt
    HMP ºÐ·Î(ÝÂÖØ)
  • metabolic shunt
    ´ë»ç ºÐ·Î(ÓÛÞóÝÂÖØ)
  • shunt
    ºÐ·Î(ÝÂÖØ)
  • adenosine monophosphate
    ÀÏÀλê(ìéìÝß«)¾Æµ¥³ë½Å
  • "adenosine-3',5'-cyclic monophosphate"
    ¾Æµ¥³ë½Å-3'-5'-°í¸® ÀÏ(ìé)Àλ꿰(×òß«ç¤)
  • "uanosine-3', 5'-cyclic monophosphate"
    "±¸¾Æ³ë½Å-3`,5'-°í¸® ÀÏÀλê(ìé×òß«)"
  • hexose monophosphate oxidative pathway
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º »êÈ­°æ·Î (ß«ûùÌèÖØ)
  • hexose monophosphate pathway
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º °æ·Î(ÌèÖØ)
  • nucleoside cyclic monophosphate
    °í¸® ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å
  • nucleoside monophosphate
    ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å
  • nucleoside monophosphate kinase
    ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å Ä«À̳×À̽º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arterioportal shunt
    µ¿¸Æ¹®¸Æ´Ü¶ô
  • intracardiac shunt
    ½ÉÀå³»´Ü¶ô
  • shunt
    ¼ÇÆ®, ´Ü¶ô
  • splenorenal shunt
    ºñ½ÅÁ¤¸ÆÀü·ù¼ú
  • TIPS [=transjugular intrahepatic portosystemic shunt]
    °æ°æÁ¤¸Æ°£³»¹®¸ÆÁ¤¸Æ´Ü¶ô¼ú
  • transjugular intrahepatic portosystemic shunt [=TIPS]
    °æ°æÁ¤¸Æ°£³»¹®¸ÆÁ¤¸Æ´Ü¶ô¼ú
  • ventriculocaval shunt
    ³ú½Ç»ó´ëÁ¤¸Æ´Ü¶ô(¼ú)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TMP thiamine monophosphate; thymidine monophosphate; thymidine-5'-monophosphate; thymolphthalein monopho...
B-T shunt Blalock-Taussig shunt
HMP Shunt Hexose Mono-Phosphate Shunt
LP shunt Lumbo-Peritoneal shunt
VA shunt Ventriculo-Atrial shunt
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HMPS Hexose monophosphate shunt
HMS Hexose-monophosphate shunt
DSRS Distal splenorenal shunt
PVS Peritoneo Venous Shunt
PCS Portacaval shunt
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hexose monophosphate shunt
    ÀÏÀλê Çí¼Ò½º ¼ÇÆ®
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine monophosphate
    ¾Æµ¥³ë½Å ÀÏ Àλê, ÀÏÀÎ»ê ¾Æµ¥³ë½Å
    ¾Æµ¥´Ñ°ú ¸®º¸½ºÀÇ °áÇÕ¹°ÀÎ ¾Æµ¥³ë½Å¿¡ ÀλêÀÌ ¿¡½ºÅ׸£ °áÇÕÇÑ ¸ð³ë´ºÅ¬·¹¿ÀŸÀ̵åÀÇ ÀÏÁ¾. ÀλêÈ­µÇ¾î °í¿¡³ÊÁö È­ÇÕ¹°ÀÎ ¾Æµ¥³ë½Å 2Àλê, 3ÀλêÀÌ »ý±ä´Ù. ÀλêÀÌ ¸®º¸½ºÀÇ C5 Å͹̳¯¿¡ °áÇÕÇÑ °Í°ú C3 Å͹̳¯¿¡ °áÇÕÇÑ 2Á¾ÀÇ À̼ºÃ¼°¡ Á¸ÀçÇϰí ÀüÀÚ´Â ±ÙÀ° µî¿¡¼­ º¼ ¼ö ÀÖÀ¸¸ç, ÈÄÀÚ´Â È¿¸ð ÇÙ»êÀÇ °¡¼öºÐÇØ µîÀ¸·Î ¾ò°Ô µÈ´Ù. ¾çÀÚ°¡ ¸ðµÎ ¹°¿¡ Àß ³ìÁö ¾Ê´Â ħ»ó °áÁ¤ÀÌ´Ù.
  • anteriovenous shunt appliance
    µ¿Á¤¸Æ Ãø·ÎÀåÄ¡
  • arteriovenous shunt
    µ¿Á¤¸Æ ´Ü¶ô
  • intracardiac shunt
    ½ÉÀå ³» ´Ü¶ô
  • juxtamedullary shunt
    ¼öÁú ±ÙÁ¢ºÎ ´Ü¶ô
  • shunt cyanosis
    ºÐÇÕ¼º û»öÁõ
    »ê¼Ò ºÒÆ÷È­ Ç÷¾×ÀÌ ½ÉÀå ¶Ç´Â ´ëÇ÷°üÀÇ µ¿¸Æ Ç÷¾×¿¡ È¥ÇÕµÊÀ¸·Î½á ¹ß»ýÇϴ û»öÁõ.
  • shunt-in personality
    ÀÚÆó¼º ÀΰÝ
  • splenorenal shunt
    ºñ½ÅÁ¤¸Æ Àü·ù¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
pentose monophosphate shunt <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
hexose monophosphate shunt The main metabolic pathway in activated neutrophils, rendering them relatively insensitive to inhibitors of oxidative phosphorylation. Congenital deficiency of the first enzyme in the shunt, glucose 6 phosphate dehydrogenase, produces a sensitivity to infection similar to that seen in chronic granulomatous disease.
(18 Nov 1997)
adenosine 3',5'-cyclic monophosphate An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known.
Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate.
Acronym: cAMP
(05 Mar 2000)
adenosine monophosphate <chemical> Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
Chemical name: 5'-Adenylic acid
(12 Dec 1998)
guanosine 5'-monophosphate A major component of ribonucleic acids.
Synonym: guanine ribonucleotide, guanosine 5'-monophosphate.
Guanylic acid reductase (GMP reductase), an enzyme that catalyses the reaction of GMP with NADPH producing IMP, NH3, and NADP+; a part of the purine salvage pathway.
Guanylic acid synthetase (GMP synthetase), an enzyme catalyzing the reaction of l-glutamine, XMP, and ATP to produce GMP, l-glutamate, AMP, and pyrophosphate; a key step in purine biosynthesis.
Acronym: GMP
(05 Mar 2000)
guanosine monophosphate A ribonucleotide which consists of the nitrogenous base guanine linked to the sugar ribose and which has a phosphate group attached to the 5th carbon atom of the ribose.
(09 Oct 1997)
cyclic guanosine monophosphate A cyclic version of the nucleotide guanosine monophosphate. It plays a role in communicating vision from the eyes to the brain.
(09 Oct 1997)
cyclic uridine 3',5'-monophosphate A cyclic nucleotide involved in metabolic regulation; inhibits the growth of some tumours.
(05 Mar 2000)
cytidine monophosphate A cytosine ribonucleotide (where the nitrogenous base cytosine is linked to the sugar ribose and a phosphate group) that helps make glycoproteins (a protein linked to a sugar or polysaccharide).
(09 Oct 1997)
cytidine monophosphate n-acetylneuraminic acid <chemical> A nucleoside monophosphate sugar which donates n-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.
Chemical name: D-glycero-beta-D-galacto-2-Nonulopyranosonic acid, 5-(acetylamino)-3,5-dideoxy-, 2-(hydrogen 5'-cytidylate)
(12 Dec 1998)
xanthosine 5'-monophosphate The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis.
Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid.
(05 Mar 2000)
hexose monophosphate pathway <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
nucleoside-monophosphate A nucleotide, e.g., AMP.
(05 Mar 2000)
deoxycytidine monophosphate <chemical> Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions.
Chemical name: 5'-Cytidylic acid, 2'-deoxy-
(12 Dec 1998)
dolichol monophosphate mannose <chemical> A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins.
Chemical name: beta-D-Mannopyranose, 1-ester with dolichol dihydrogen phosphate
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic adenosine monophosphate
    =CYCLIC AMP
  • shunt
    À» ´Ý´Ù
  • shunt
    ¿·À¸·Î µ¹¸®´Ù;Á¦°ÅÇÏ´Ù;ÇÑÂÊÀ¸·Î ºñŰ´Ù;Ãø¼±¿¡ ³Ö´Ù;Àüö(ÀÔÇÑ)ÇÏ´Ù;ÇÑÂÊÀ¸·Î ºñŰ´Ù;Ãø¼±À¸·Î µé¾î°¡´Ù;Àüö(±â)ºÐ·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á